Home
About
Overview
Sharing Data
ORCID
Help
History (1)
How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria.
How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria. J Allergy Clin Immunol Pract. 2015 Jul-Aug; 3(4):648.
View in:
PubMed
subject areas
Anti-Allergic Agents
Anti-Asthmatic Agents
Humans
Immunoglobulin E
Omalizumab
authors with profiles
Allen P. Kaplan